Skip to main content
. 2013 Sep 17;48(8):668–679. doi: 10.1310/hpj4808-668

Table 3.

Incidence of most common adverse reactions (incidence at least 2% higher than placebo) associated with dimethyl fumarate 240 mg twice daily in placebo-controlled trials (studies 1 and 2)1

Adverse reactions Dimethyl fumarate (n = 769) Placebo (n = 771)
Flushing 40% 6%

Abdominal pain 18% 10%

Diarrhea 14% 11%

Nausea 12% 9%

Vomiting 9% 5%

Pruritus 8% 4%

Rash 8% 3%

Albumin urine present 6% 4%

Dyspepsia 5% 3%

Erythema 5% 1%

AST increased 4% 2%

Lymphopenia 2% <1%